SureSelect Cancer CGP Assay - MII IG Kerndatensatz-Modul Molekulares Tumorboard v2027.0.0-ballot.1

MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 - Germany

This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

DeviceDefinition: SureSelect Cancer CGP Assay

German

Profile: MII PR MTB Panel DeviceDefinition

MII EX MTB Panel Gene List
geneList: MII VS MTB Panel CGP
scope: SNV-Detektion

manufacturer: Agilent Technologies

DeviceNames

Name

Type

SureSelect Cancer CGP Assay

User Friendly name

type: Genpanel

Capabilities

Type

SNV-Detektion

url: https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/DeviceDefinition/mii-dd-mtb-panel-cgp

onlineInformation: https://pathologie-ccm.charite.de/fileadmin/user_upload/microsites/m_cc05/pathologie-ccm/00_formulare_documente/00_molekularpathologie/Anlage_Genlisten_NGS-Panel.pdf

note:

602 Gene; nur SNVs.

IG © 2024+ Medizininformatik-Initiative. Package de.medizininformatikinitiative.kerndatensatz.mtb#2027.0.0-ballot.1 basiert auf FHIR 4.0.1. Erstellt 2026-09-15
Links: Inhaltsverzeichnis | QA-Bericht | netzwerk-universitaetsmedizin.de | medizininformatik-initiative.de | Impressum
HL7®, FHIR® and the FHIR flame design are registered trademarks of Health Level Seven International. Their use does not constitute endorsement by HL7.